[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-NVCR":3,"homepage-market-summary":31,"stock-news-NVCR":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"NVCR","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"NovoCure Limited Ordinary Shares","Nasdaq",null,"SURGICAL & MEDICAL INSTRUMENTS & APPARATUS","NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.","1,605","St. Helier",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},14.97,15.27,15.88,14.9,15.2,-0.23,-1.51,1749174.581123,19655,15.2194,21.4506,9.82,1627901.8385375538,44.3,2769,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",0.53,202,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.24,54.01,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.2,111.75,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.9,81.77,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.47,63.75,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.87,171.58,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.46,49.73,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",1.06,41.1,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",2.98,41.16,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.04,111.65,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":162,"name":163,"price":164,"change":138,"is_up":40},"QQQ","Invesco QQQ Trust",759.69,{"ticker":166,"name":167,"price":168,"change":47,"is_up":40},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":170,"name":171,"price":172,"change":173,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"count":175,"articles":176},13,[177,183,189,195,201,206,212,218,223,228,233,238,244],{"title":178,"link":179,"pubDate":180,"description":181,"source":182},"NVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4wFBVV95cUxOanYzaXpKd3g5bHBJYlhybG9aOWZKQzZfVUEtaXNRSUxjSlBzSTJnQTVIWUtmdE9JTVZONDdGa2ZTXzJFWEZnakRwaTlwLVFSNkRHR0lJM1h2MERDektpOXJCX0JnM0xlcF9BWDdfakJzdzl6NXFKNS1OUlV4SGh6VFNGeUQ3eG9TU1J3a0o5aWJzdVhMNHBhc3lhMURLUmlMXzF6MUR2dEhDZmljQ2ItVWxxR2gzU1lvWGlKR0QtbmUxQnRsQWRaMTE3MVF6OTBHSEh6TlVVM1F1eTUtczMwTEJfTQ?oc=5","Sun, 04 Oct 2026 20:36:38 GMT","NVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial Stocktwits","Stocktwits",{"title":184,"link":185,"pubDate":186,"description":187,"source":188},"A results call is set for 8 a.m. Oct. 29, when Novocure will discuss third-quarter results. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxQSEdtTDhXOHNlS1NPQjNOMWkzYThGMHoxVXlwRFlBTFVxNXdtWTFYeGRPcFJDeGNuU1dId282SXY3b3dtOTlSSWpPUTNfVXhLRHl4ekhLZ3Z6QTBlTDhDbUFVWGNhSnZjN1NJN0Z5ZlFHMThvcmxKQ3QzT3R4b1hVa0YwN2lIbkhQY2VlV3JHTWg3VWlsOU91bTFJM2cyUGFDbmJKTg?oc=5","Thu, 01 Oct 2026 11:00:00 GMT","A results call is set for 8 a.m. Oct. 29, when Novocure will discuss third-quarter results. Stock Titan","Stock Titan",{"title":190,"link":191,"pubDate":192,"description":193,"source":194},"Novocure Stock Price Forecast. Should You Buy NVCR? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE9OMG96a09BNlo2S3lSRVYzR1JIdUg1TlpzblhialVIbDBzclhyZ1A0VmNxdTV4VmVILW84bkc4RDFQeE9FTnpQbw?oc=5","Fri, 25 Sep 2026 22:25:01 GMT","Novocure Stock Price Forecast. Should You Buy NVCR? StockInvest.us","StockInvest.us",{"title":196,"link":197,"pubDate":198,"description":199,"source":200},"NVCR Oct 2026 19.000 call (NVCR261016C00019000) Interactive Stock Chart - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTFA4c3NxODRWT2xrYWZRQkUxd1BNY09Ta2NBQnpTbVJCUUZhY2FZdWFNbkd1MTBleWVsc2RYX2RuLXFZVG5jb1puU2lGU0JRQ0VYWUtOZjB0QXJrd0xUUmxJeGYwUWxBa3JrRHlLbGx3?oc=5","Fri, 02 Oct 2026 07:05:43 GMT","NVCR Oct 2026 19.000 call (NVCR261016C00019000) Interactive Stock Chart Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":202,"link":203,"pubDate":204,"description":205,"source":182},"Why NVCR Stock Is Surging Nearly 30% In Overnight Trading - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxQS2xlN1dqWHd3dVpxTG1TZmJJZEN2RE1Qb0kyd0JaQXlEUmJSazBzZk80NE9CY2FTbVd0QVNqME0xTFNNRV9mYUpEUUh2bEQ2bjE4dV9od3JDNmtHM19Oa3Q2M01Dd3ZpQ1FMVmdCc2VDZU84M1VmcFBUcHF6WllYckxsbkdGel82WGozbXJuNTI5clRfUWFRanpNMWFxblRiN3BfYk1TdVRCN3JIc3ZfT3hVLXlPTlgxRlFWMUt6aUlqajhrZ18xZlY3Y2tyRUNHV0gwSTNPSzdoWFV4?oc=5","Mon, 28 Sep 2026 18:15:58 GMT","Why NVCR Stock Is Surging Nearly 30% In Overnight Trading Stocktwits",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Responsive Playbooks and the NVCR Inflection - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxPSUd6dWJXMUVOOXBqaW5PTDZfcHNnVEM3UUNHQ1ZxNlN2N1diNlQ0SVktWUFsd25jYmdPcnpqRG5OVGtPd3lydkFkNHRxZ2JQUFVrSEtWWmxJMWFVTjJja1R2eVl4SzhYZ3BsbHJfdzBuZ0ZDMkphMG1sNS1sYTJwU0ZYaEFieWVTOWZMcmJuSVh6d1pKX3NZR0FLTUpEX0d0N2ZONmstVUh5QW5kcVB0U29IY0RnT3FQTzFXUWljWFVXdw?oc=5","Sat, 03 Oct 2026 03:50:02 GMT","Responsive Playbooks and the NVCR Inflection Stock Traders Daily","Stock Traders Daily",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"Is NovoCure (NVCR) Undervalued On TTFields Validation And Board Change? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 24 Sep 2026 12:29:08 GMT","Is NovoCure (NVCR) Undervalued On TTFields Validation And Board Change? Simply Wall Street","Simply Wall Street",{"title":219,"link":220,"pubDate":221,"description":222,"source":188},"Japan approves a wearable device to use with chemo for advanced pancreatic cancer. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQUzY2S2pNUE52WUFBS21EeW4wSE9FZXd2M0daU05nNG0tYmoybkRNdDcxckRyNWpranRmTVhwSGVFckdfbTg2OTVHeUVrSXlvenc4VWdoYndzNW1idlloODJHV3JpbUIzZkt3RVVHZnBlaTFhdW9WUlkxWldCYm5MUzNhVkRXaEE2NmxtZmhsdFBpV1VvRzdBdjUzTVREcGVWUnVHOWp1d3hMbmdKYWQ0MDJJcGdWYjY0T3ZzLUFR?oc=5","Thu, 01 Oct 2026 13:00:00 GMT","Japan approves a wearable device to use with chemo for advanced pancreatic cancer. Stock Titan",{"title":224,"link":225,"pubDate":226,"description":227,"source":200},"NVCR Oct 2026 18.000 call (NVCR261016C00018000) Interactive Stock Chart - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMibkFVX3lxTE9HaWxmbDF4dUFvRHY2Z09jcDVld2hxSXQ3MzBYekFESmxRLWNWa1lRRjktNVprZE40SXIwTkVYTldJVWVfTEc3RlBrTG1QbWNWZWJ4OWR1aGtQVHFLWHQxZ1FuN1dOdFVQZThmc0p3?oc=5","Tue, 06 Oct 2026 07:57:00 GMT","NVCR Oct 2026 18.000 call (NVCR261016C00018000) Interactive Stock Chart Yahoo! Finance Canada",{"title":229,"link":230,"pubDate":231,"description":232,"source":182},"Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today? - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxOVzhYY1pwTDRyLVhfeFdCVVhLdWYySURGeEtSQmJ2UmpzQTlrNVROUW1HV1VrZVNndXlMenhaOHBpLXQtMjFLc3NTOW51MzlkNTNfQVZQVjh5bnp2bHhrTk1ObTY2bWpDNjdoVEE3RnZVWXp0Q0EwUzFUTXJwSjVfei1CbjFUTEJNZDJPVzVhakxTUE85SUc1RlhqSVlqcXM2NXIxRzZBbE4xRVRhd3pfTFk3SkU5RWhIdmtjMw?oc=5","Mon, 05 Oct 2026 00:01:14 GMT","Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today? Stocktwits",{"title":234,"link":235,"pubDate":236,"description":237,"source":217},"NovoCure (NVDA) Could Be 69% Undervalued After Japan Pancreatic Cancer Approval - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 07 Oct 2026 05:03:43 GMT","NovoCure (NVDA) Could Be 69% Undervalued After Japan Pancreatic Cancer Approval Simply Wall Street",{"title":239,"link":240,"pubDate":241,"description":242,"source":243},"Novocure stock heads toward October 29 results after Japan approval - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxNZjZrZ0kyeUROMHJlMmlLS25mdXdWcUQ4al9xNHFnTTZQYnUwQi1BTlREeFloZXJkME5qY2hQd0tYUmhmc3kxeUl0VjhuZWlQMG9VS1dUQjI2d202eHFYSWNvOFowUTRhYVp0cEdKcVl5ME5UVC1GSzlQdHlKZUVEMWg4bVhicWNhN255cUlDeklFamt2NjRIb3hsYnlKNjRKdm54WU9KYmRya2JsZUc3c243U2t1ZE5OS25QUk04dWY4aTVYRnJRclF3?oc=5","Tue, 06 Oct 2026 13:26:17 GMT","Novocure stock heads toward October 29 results after Japan approval AD HOC NEWS","AD HOC NEWS",{"title":245,"link":246,"pubDate":247,"description":248,"source":243},"NovoCure stock gets Japan approval for Optune Pax - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxOTHVQaDlsLWdNYVlGZWNjZ0tJTkRvRkJzejNiWGxEYlBFUVNiaTVnZHBqVHc0S25sWGF0dEVpZkdCdVhyRV9DNExqdEhGaDQ2RXdRX3NvOGdMTXNudm0yOTBadTJVYVBuaHhCUFFINWJoc0o1UVZtMHhDcGRpc0x3TGo5bVhpT29Ncm5uaWk5bzB3cm52SHNOUTBzdjg1TDIxN1lyT0dmSUVGRUJNVTNNam13?oc=5","Sun, 04 Oct 2026 19:30:12 GMT","NovoCure stock gets Japan approval for Optune Pax AD HOC NEWS"]